2017
DOI: 10.5650/jos.ess17032
|View full text |Cite
|
Sign up to set email alerts
|

Development and Optimization of Orally and Topically Applied Liquid Crystal Drug Formulations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0
2

Year Published

2019
2019
2021
2021

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 16 publications
(18 citation statements)
references
References 68 publications
(20 reference statements)
0
16
0
2
Order By: Relevance
“…Release Test of TA from Spray Preparations Regenerated cellulose membrane (Cellulose tube 24/32 with a pore size of 50 Å, Eidia Co., Ltd., Tokyo, Japan) was set in a Franz type diffusion cell (receiver volume: 6.0 mL, effective diffusion area: 1.77 cm 2 ) as described previously. 8,10,11) Then, the spray formulation or commercial formulation (Aftach ® Adhesive Tablet or Kenalog ® in Orabase) containing the same amount of TA (25 µg) was applied onto the regenerated cellulose membrane after applying 200 µL of artificial saliva (Salibeht ® ) on the membrane. The spray formulation was applied with a pipette over the area to ensure uniform distribution and Kenalog ® was spread with a spatula.…”
Section: Holding Areamentioning
confidence: 99%
See 2 more Smart Citations
“…Release Test of TA from Spray Preparations Regenerated cellulose membrane (Cellulose tube 24/32 with a pore size of 50 Å, Eidia Co., Ltd., Tokyo, Japan) was set in a Franz type diffusion cell (receiver volume: 6.0 mL, effective diffusion area: 1.77 cm 2 ) as described previously. 8,10,11) Then, the spray formulation or commercial formulation (Aftach ® Adhesive Tablet or Kenalog ® in Orabase) containing the same amount of TA (25 µg) was applied onto the regenerated cellulose membrane after applying 200 µL of artificial saliva (Salibeht ® ) on the membrane. The spray formulation was applied with a pipette over the area to ensure uniform distribution and Kenalog ® was spread with a spatula.…”
Section: Holding Areamentioning
confidence: 99%
“…Self-organizing lipids (SOLs) form non-lamellar lyotropic liquid crystals (NLLCs) and have been a recent focus as a new type of pharmaceutical additive [6][7][8][9][10][11] because they show high drug entrapment ability, high adhesion to biological membranes, sustained drug release ability, and enhanced biological membrane permeability and absorption. SOLs may be a next-generation material for biomimetic drug de-livery systems such as liposomes.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Одной из важнейших биофармацевтических характеристик любой лекарственной формы является высвобождение лекарственного вещества. На стадии фармацевтической разработки для микроэмульсионных и ЖК-носителей можно использовать методы, основанные на диализе через полупроницаемую мембрану [5,[20][21][22]. Для изучения кинетики высвобождения водорастворимых лекарственных веществ была использована модельная система: перенос водорастворимого красителя Родамина С из образцов микроэмульсии и ЖК, помещенных в диализный мешок, в физиологический раствор при Т = 37°С.…”
Section: экспериментальная частьunclassified
“…Скорость переноса веществ из лиотропных ЖК или микроэмульсии через диализную мембрану зависит от многих факторов: структурной организации носителя (например, типа ЖК), содержания водной фазы в составе носителя, гидрофильности или липофильности переносимого вещества [5,21]. В обратной микроэмульсии диффузия водорастворимого красителя будет происходить за счет столкновения и слияния капель.…”
Section: экспериментальная частьunclassified